|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4504 USD | -3.08% |
|
-5.97% | -77.92% |
| 05-14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
The Oncology Institute, Inc. provided earnings guidance for the year 2022. For the year, Revenue expected to be in the range of $270 million to $310 million, representing approximately 33% to 53% growth over 2021 revenue.
| 1st Jan change | Capi. | |
|---|---|---|
| -77.92% | 33.53M | |
| +22.65% | 86.96B | |
| -23.68% | 75.65B | |
| +0.35% | 26.97B | |
| +7.45% | 17.89B | |
| -13.47% | 16.58B | |
| +2.68% | 15.73B | |
| +69.13% | 13.01B | |
| +74.99% | 12.92B | |
| +4.48% | 12.5B |
THE ONCOLOGY INSTITUTE, INC. 